JANUARY 2022

Welcome to 2022! You made it!

You might say that "making it" is the theme of the year. If your new year goals include making DNA just when you need it and taking more control of your lab experiments, we should talk.
UPCOMING EVENTS
February 5 - 9, 2022 | Boston, MA, USA | Booth #624

  • Spotlight Talk | Feb 7 4pm: SYNTAX System - Benchtop Enzymatic DNA Synthesis Delivers On-Demand Oligos, Same-Day Results
March 27-30, 2022 | Palm Springs, CA USA | Booth #220

  • Technology Showcase | Mar 29 7:30 - 8:30am | Smoketree AB

  • EyeOpener Talk | Mar 30 8:30 - 9:30am: Using Enzymatic DNA Synthesis to Build Custom Library Adaptors for Controlling Real-Time Nanopore Sequencing, presented by Tim Mercer, Ph.D.
Postponed to April 12-14, 2022 | Oakland, CA USA | Booth #34
Postponed to June 6-9, 2022 | Orlando, FL USA | Jade-Lexington Suite
>> WANT MORE? Check Out Our Events
IN THE NEWS
Thomas Ybert, Ph.D., DNA Script CEO and co-founder, spoke with podcast host Theral Timpson on how the SYNTAX System will change the synthetic biology landscape and democratize access to DNA synthesis.
DNA Script expanded its Series C funding round to close at a total of $200M. This funding enables the company to drive the commercialization of the SYNTAX Platform, which will empower labs of all sizes make DNA on demand.
NEW TECHNICAL RESOURCES
POSTER: Presented at ASHG 2021
Enzymatic DNA Synthesis (EDS) Enables Rapid and Broad-Based Access to Synthetic Oligos Needed for the Genetic Analysis and Functional Characterization of the SARS-CoV-2 Virus
POSTER: Presented at ESHG 2021
Enzymatic DNA Synthesis (EDS) enables decentralized and same-day access to DNA for critical study, developments and diagnosis to fight SARS-CoV-2
‌
For Research Use Only. Not for use in diagnostic procedures.
You are receiving this email because of your work in molecular biology and genomics applications.
If you no longer want to receive emails from DNA Script, click Unsubscribe below.